André A. Santos
PhD (2015) in Biochemistry (Microbial Biochemistry), Institute of Chemical and Biological Technology (ITQB) António Xavier, Universidade NOVA de Lisboa
Post-Doctoral Fellow, iMed.ULisboa, Faculdade de Farmácia, Universidade de Lisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
André A. Santos aims at understanding how gut microbiota-derived metabolites may impact on liver disease. He focuses his project on diet mice models and correlates results with human samples to identify potential metabolites involved in the onset and progression of non-alcoholic fatty liver disease. Finally, his ultimate goal is to target gut microbiota as a potential new liver disease therapeutic approach.
Santos AA, Venceslau SS, Grein F, Leavitt WD, Dahl C, Johnston DT, Pereira IA. A protein trisulfide couples dissimilatory sulfate reduction to energy conservation. Science 2015; 350: 1541-5.
Leavitt WD, Bradley AS, Santos AA, Pereira IA, Johnston DT. Sulfur isotope effects of dissimilatory sulfite reductase. Front Microbiol 2015; 6: 1392.
Duarte AG, Santos AA, Pereira IA. Electron transfer between the QmoABC membrane complex and adenosine 5′-phosphosulfate reductase. Biochim Biophys Acta 2016; 1857: 380-6.
Pereira A, Santos A, Tacao M, Alves A, Henriques I, Correia A. Genetic diversity and antimicrobial resistance of Escherichia coli from Tagus estuary (Portugal). Sci Total Environ 2013; 461: 65-71.